Effect of Fasting Therapy on Blood Glucose Control and Islet Function in Newly Diagnosed Type 2 Diabetic Patients

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate Effect of Fasting Therapy on Blood Glucose Control and Islet Function in Newly Diagnosed Type 2 Diabetic Patients.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: First Affiliated Hospital, Sun Yat-Sen University
• Treatments: Insulin; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• aged from 27-65 years

• overweight or obese (body mass index[BMI] ≧25.0 kg/m2)

• The function of heart, liver, kidney is normal

• Newly diagnosed Type 2 diabetes according to the diagnostic criteria and classification of diabetes mellitus in 1999 World Health Organization standards with a fasting plasma glucose level ranged from 7.0 mmol/l to 16.7 mmol/l

• sign a consent form

Exclusion Criteria:

• Females who were pregnant or experiencing a menstrual period

• Abnormal function of heart, liver, kidney

• Aged below 25 or over 70

• Malignancy, hematopathy, active tuberculosis, peptic ulcer with gastric bleeding, binge-eating disorder, psychiatric disease, congestive heart failure, cancer or a history of cancer, unstable coronary artery disease

• With acute or severe chronic diabetic complications

• Without an informed consent

• Severe intercurrent illness

• Tested positive for glutamic acid decarboxylase antibody

• Patients with maturity onset diabetes in youth and mitochondria diabetes mellitus

• Other situations which the investigators think that it is inappropriate to include